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LETTER TO THE EDITOR
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A pediatric patient with sickle cell disease presenting
with severe anemia and splenic sequestration in the setting
of COVID-19
and blood cultures were sterile. An ultrasound showed an enlarged

To the Editor:
Pediatric patients with sickle cell disease have varied clinical

spleen that measured 12 × 3.4 × 9.9 cm. A chest X-ray revealed mild

experiences. Splenic sequestration is a potentially life-threatening

cardiomegaly but no radiographic evidence of an acute pulmonary

complication of sickle cell disease, estimated to have a prevalence

process.

of approximately 12%. Splenic sequestration occurs most commonly

He was transfused with multiple aliquots of packed red blood cells.

in the youngest pediatric patients, with a median age of 1.4 years.

The patient’s irritability resolved after the initial aliquot of red blood

The majority of patients with splenic sequestration present with

cells and he returned to baseline activity. His fever did not recur and

additional clinical symptoms, most commonly fever, and many with

he did not manifest any other symptoms of COVID-19. Prior to dis-

a concomitant infection.1 The effects of COVID-19 on patients with

charge, the patient’s anemia had improved to hemoglobin 10.3 g/dL

sickle cell disease are not yet well described. We present a case of a

and hematocrit 30.4% with reticulocytes 8.2%, and his thrombocytope-

pediatric patient with sickle cell disease who presented with severe

nia improved to platelet count 109 000/µL from 59 000/µL. His serum

anemia in the setting of splenic sequestration and COVID-19. We are

ferritin had trended down to 867 ng/mL. On his physical exam, his

not aware of any other published cases of COVID-19 presenting in this

splenomegaly had improved. He was hospitalized for 4 days, and he

manner.

remained otherwise asymptomatic during hospitalization and for over

The patient is a 2-year 9-month-old male diagnosed with homozy-

6 weeks posthospitalization.

gous hemoglobin SS disease. He presented to his hematologist’s

Since the emergence of COVID-19 in December 2019, patients have

outpatient clinic with irritability and an isolated fever of 102◦ F approx-

been closely followed in an attempt to characterize and treat the clini-

imately 9 h prior to arrival. He received one dose of ibuprofen at home

cal manifestations of this pandemic. The number of patients diagnosed

at the time of fever, with no return of fever prior to presentation to the

with COVID-19 has increased significantly as pathogen detection cam-

clinic. Patient’s review of symptoms was otherwise negative with no

paigns have become more widespread. Most children diagnosed with

upper respiratory symptoms, no decrease in oral intake, no diarrhea,

the disease have been reported to present with mild symptoms; fever

and no known sick contacts. The patient’s medical history is significant

and cough are the most common clinical manifestations in children

for five prior hospitalizations during which he was transfused, but

with COVID-19. These may be accompanied by symptoms of fatigue,

had no history of acute chest syndrome or splenic sequestration,

myalgia, upper respiratory tract symptoms, sore throat, headache,

with normal splenic ultrasounds documented on prior admissions.

dizziness, and gastrointestinal symptoms.2 While severe complica-

His medications included hydroxyurea, penicillin-VK, and folic

tions occur less frequently in the pediatric population with COVID-19,

acid.

severe morbidity and mortality has been documented in the pediatric

In the clinic, the patient was afebrile, tachycardic to 152 beats per

population.3

minute, with a blood pressure of 104/61 mmHg and no tachypnea or

Patients with sickle cell disease are prone to infectious complica-

desaturations noted at room air. His physical exam was significant for

tions, however, the effects of COVID-19 on this pediatric population

irritability and a palpable spleen edge approximately 1.5 cm below the

are not yet well documented. Limited descriptions of pediatric patients

costal margin. The patient had no jaundice or scleral icterus. Initial

with sickle cell disease presenting with acute chest syndrome and

blood work was notable for an undetectable hemoglobin level. He had

COVID-19 have been published,4 however, there have been no docu-

total serum bilirubin 2 mg/dL, aspartate aminotransferase 72 U/L, ala-

mented cases of other complications of sickle cell disease in the setting

nine aminotransferase 10 U/L, LDH 815. His serum ferritin was ele-

of a COVID-19 infection in pediatric patients as of yet. In this case of

vated to 4655 ng/mL.

COVID-19, the patient had one isolated fever that did not recur and

Blood culture was drawn and the patient was empirically treated

had no apparent usual symptoms of a viral syndrome. While the patient

with ceftriaxone. A rapid respiratory viral panel detected no common

presented with a severe presentation of splenic sequestration with an

viral pathogens. Given the environment of the COVID-19 pandemic,

undetectable hemoglobin, he had a mild clinical course during hospi-

a COVID-19 polymerase chain reaction test was sent that detected

talization, with no additional apparent morbidity related to COVID-

viral genome. A urinalysis showed no signs of a urinary tract infection

19. We must keep COVID-19 in the differential diagnosis even without
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classic symptoms of the virus, and be prepared for a great variety of
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clinical presentations.
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We document the first case of a pediatric patient with sickle cell anemia who presented in a splenic sequestration crisis in the setting of
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an infection with COVID-19. This report adds to the developing body
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of knowledge of the varied presentations of COVID-19 in pediatric
patients, especially in those who are immunocompromised.
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